Skip to main content
Caplight Logo









Craif Inc.

Craif Inc.

Private
TokyoHealthcare & Life Scienceshttps://craif.com/

Last Round

Series D

Aug 18, 2026

Est. Valuation

$100M

Total Funding Raised

$77M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Craif Inc. is a biotechnology company that develops and provides exosome-based liquid biopsy tests and AI-driven diagnostic platforms for early cancer detection.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

cancer screeningliquid biopsyurinary microRNAearly cancer detectionmedical AIprecision medicinenon-invasive diagnosticsbiomarker researchhealthcare analyticsdiagnostic servicepreventative healthat-home testingbiotechusage-based billinghealthtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Craif Inc. Comparables

Compare Craif Inc. with similar companies based on industry and business-model similarity.

Craif Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HIROTSU BIO SCIENCE INC.
84%
MiRNA Scientific
76%
Mirxes
74%

Craif Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DAug 18, 2026
IPODec 8, 2025
Series CApr 28, 2025
Series CDec 23, 2024
Series B ExtensionApr 12, 2022
Series B
Nov 2, 2021

Key People

Founding team and executive leadership

Ryuichi Onose

CEO

Executive Team

Mika Mizunuma

Chief Operating Officer

Executive Team

Craif Inc. Investors

Notable investors and investment history

Craif Inc. investors
InvestorRounds
Mori Trust Co., Ltd.Series A
Tokio Marine & Nichido Fire InsuranceSeries B Extension, Series B
Saisei VenturesSeries B Extension
Unreasonable CollectiveSeries C
株式会社日本政策金融公庫Series D
Joyo Bank, Ltd.Series D
Global Brain CorporationSeries B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 18, 2026

    $33M round led by TAUNS Laboratories, Inc.

  • May 27, 2026

    Achieved over 3x annual growth since product release in 2022.

Craif Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Craif Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Craif Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range53
Year Founded2018
Last FundingAug 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?